Cohere Health, a leader in clinical intelligence solutions, has secured $90 million in Series C funding to expand its AI-powered platform, Cohere Unify. This investment, bringing total funding to $200 million, reinforces the company’s mission to streamline prior authorization and enhance healthcare collaboration.
Cohere Health’s $90 million Series C funding, led by Temasek with support from Deerfield Management, Define Ventures, Flare Capital Partners, Longitude Capital, and Polaris Partners, will fuel the expansion of its Cohere Unify platform. The platform modernizes utilization management (UM) by personalizing provider workflows and leveraging real-time performance data, enabling seamless collaboration between health plans and providers. This investment will drive growth into new clinical use cases and enhance Cohere’s AI-driven product portfolio, transforming clinical decision-making across healthcare.
"Our mission has always been simple: to help people receive the right care at the right time, in the right place, and with the right value," said Siva Namasivayam, CEO and co-founder of Cohere Health. The Cohere Unify platform streamlines prior authorization, auto-approving up to 90% of requests, which reduces provider friction and accelerates patient access to care. By integrating clinical evidence and guidelines, the platform ensures precision and efficiency, processing over 12 million requests annually for more than 600,000 providers nationwide.
"Since the founding of the company, we have believed Cohere's approach to AI is distinctive because it brings real clinical intelligence to the table," said Michael Greeley, Co-Founder & General Partner at Flare Capital Partners. Cohere’s clinician-led, responsible AI-first approach ensures transparency and accountability, achieving a 93% provider satisfaction rating. Unlike traditional systems, Cohere reimagines prior authorization to align physicians and health plans, reducing administrative burdens and enhancing patient outcomes.
Cohere Health’s impact is evident in its industry accolades, including recognition in the Gartner Hype Cycle for U.S. Healthcare Payers, a Top 5 LinkedIn Startup ranking for 2023 and 2024, and three KLAS Points of Light awards. The company’s growth, marked by an expanded client base and strengthened leadership, positions it to lead in clinical intelligence. Looking ahead, Cohere aims to further integrate AI into areas like care management, ensuring clinical insights drive transparent, value-based healthcare decisions.
Cohere Health’s latest funding marks a pivotal step in redefining healthcare efficiency. By scaling its AI-driven platform and expanding clinical applications, the company continues to lead the transformation of prior authorization, delivering faster, smarter care for millions.
Cohere Health is a clinical intelligence company delivering AI-powered prior authorization solutions that streamline access to quality care by improving collaboration between physicians and health plans. Cohere works with nearly 600,000 providers and processes over 12 million prior authorization requests annually. Its AI auto-approves up to 90% of requests for millions of health plan members. Cohere has been recognized in the Gartner® Hype Cycle™ for U.S. Healthcare Payers, named a Top 5 LinkedIn™ Startup in 2023 and 2024, and is a three-time KLAS Points of Light award recipient.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.